INTRODUCTION
Pregnancy causes numerous changes in the woman's body. During pregnancy, the level of body immune system is reduced. Hormonal and mechanical changes increase the risk of urinary stasis and vesicoureteral reflux. These changes, along with an already short urethra and difficulty with hygiene due to a distended pregnant belly, increase the frequency of urinary tract infections (UTIs) in pregnant women [1] . Indeed, UTIs are among the most common bacterial infections during pregnancy [1] . Urinary tract infections (UTIs) are among the most common bacterial infections diseases in human [2] [3] [4] . UTIs account for more than 8 million referrals to hospitals, 1.5 million hospitalization, and 300,000 severe clinical syndromes in the United States annually [2, 5] . UTIs is an important cause of mortality and morbidity [6, 7] .
Uropathogenic Escherichia coli (UPEC) strains are the most prevalent causes of UTIs around the world [3, 8] . Based on the hypothesis, UPEC strains can transfer from the urinary tract of pregnant women who have low levels of immunity into the reproductive system [9, 10] . This maybe more common in pregnant women with history of recurrent UTIs (EUTIs). Association of bacterial vaginosis and UTIs in pregnant women have also been reported previously [10] [11] [12] .
In an overview, treatment of the cases of UTIs and vaginal infections were carried out by antibiotic therapy, but high prevalence of antibiotic resistance in the UPEC strains of clinical infections, with the attenelant prolonged severe diseases, [3, 13, 14] . According to recent epidemiological studies, UPEC strains showed a high prevalence of resistance (50-100 %) against commonly used antibiotics, including tetracycline, cefotaxime, gentamycin, ampicillin, amikacin, ciprofloxacin (5 µg/disk), cotrimoxazole, norfloxacin and cephalothin [3, 13, 14] . with to the mutable status of the antibiotic resistance in UPEC strains of clinical samples in cases of pregnant women which are of high clinical importance, the distribution of antibiotic resistance pattern should be evaluated.
Due to the uncertain status of UPEC strains in pregnant women, the present study was carried out to investigate antibiotic resistance pattern of the UPEC strains isolated from pregnant women with history of RUTIs.
EXPERIMENTAL Ethical issues
This work was approved by the ethical committee of Department of Infectious Diseases, College of Medicine, AJA University of Medical Sciences, Tehran, Iran (ref no. 20275 MD). Written informed consent was obtained from the patients or a close relative. All stages of sampling were done in such a way as to minimize pain and harm to the patients and international guidelines for human studies were followed [15] .
Study population and samples collection
Total of 240 high vaginal swab specimens were collected from pregnant women with history of RUTIs from March to December 2015. Besides, 245 high vaginal swabs were also taken from healthy pregnant women who were referred to the Obstetrics and Gynecology Centers, Iran for routine pregnancy checks. Specimens were collected from the ventral fornix without any contact with urine and external parts of reproductive system, using speculum and commercial sterile cotton-tipped swabs. All specimens were collected by an expert midwife.
Escherichia coli identification
All samples were transferred to the laboratory in a cooler with ice packs. A, 3 mL of each specimen was blended with 225 mL of Lactose Broth (LB, Merck, Germany) for 2 min at normal speed, using a Stomacher lab blender and incubated at 37 °C for 24 h. One milliliter sample of the nutrient broth culture was mixed with 9 mL of MacConkey broth (MC broth, Merck, Germany) and further incubated at 37 °C for 24 h. One loop of each tube was streaked on MacConkey agar (MC agar, Merck, Germany). A typical colony of E. coli was streaked on Eosin Methylene Blue agar (EMB agar, Merck, Germany) plates and incubated at 37 °C for 24 h. A green metallic colonies from each plate with typical E. coli morphology was selected and examined by biochemical tests, including hydrogen sulfide, citrate, urease, methyl red (MR), Voges-Proskauer (VP), Triple sugar iron agar (TSI agar) and indole.
PCR confirmation of Escherichia coli strains
Total genomic DNA was extracted from the bacterial colonies using the DNA purification kit (Fermentas, Germany) according to the instructions. The colonies were confirmed using PCR method [16] . The 10 ml bacterial DNA extract and controls were amplified with 0.5 mM primers (Forward: 5'-AGTTTGATCCTGGCTCAG -3' and Reverse: 5'-AGGCCCGGGAACGTATT CAC-3') (1343 bp), 200 mM of each dNTP (Fermentas, Germany), 2 mM MgCl2, 10 mM KCl PCR buffer and 1.0 U Taq polymerase (Fermentas, Germany). The DNA was amplified in a programmable thermal cycler (Eppendorf, Mastercycler® 5330, Eppendorf-Netheler-Hinz GmbH, Hamburg, Germany) PCR device using the following protocol: 94 ºC for 5 min, 40 cycles of 94 ºC for 1 min, 55 ºC for 1 min, 72 ºC for 2 min, and final 72 ºC for 5 min. Amplified products were stained with SYBR DNA gel stain, separated electrophoretically in 1.5 % agarose gels, and imaged using an UV transilluminator and digital capture system. E. coli ATCC 8739 and sterile distilled water were used as a positive and negative controls, respectively.
Antimicrobial susceptibility testing
Antimicrobial resistance pattern was performed by the Kirby-Bauer disc diffusion method using Mueller-Hinton agar (HiMedia Laboratories, Mumbai, India, MV1084), according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [17] . After incubating the inoculated plate aerobically at 37 °C for 18 -24 h in an aerobic atmosphere, the susceptibility of the E. coli isolates against tetracycline (30 µg/disk), cefotaxime (30 µg/disk), gentamycin (10 µg/disk), ampicillin (10 µ/disk), amikacin (30 µ/disk), imipenem (30 µ/disk), mezlocillin (30 µ/disk), ciprofloxacin (5 µg/disk), cotrimoxazole (30 µg/disk), norfloxacin (30 µg/disk), ofloxacin (5 µg/disk), nitrofurantoin (300 µg/disk), nalidixic acid (30 µg/disk), cephalothin (30 µg/disk) and clindamycin (2 µg/disk) antimicrobial agents was measured.
Results were interpreted in accordance with interpretative criteria provided by CLSI (2012). E. coli ATCC 8739 was used as quality control organisms in antimicrobial susceptibility determination.
Statistical analysis
The data were analyzed using SPSS software (version 17, SPSS Inc, United States) using Chisquare and Fisher exact tests to find any significant correlation between incidence of E. coli strains and their antibiotic resistance properties in pregnant women. Differences were considered significant at p < 0.05. Table 1 shows the total prevalence of E. coli in pregnant women with RUTIs and healthy pregnant women. All of the E. coli isolates were authenticated by the PCR amplification. Figure 1 represents the results of gel electrophoresis for E. coli bacterium. We found that 28 out of 445 (6.29 %) swab samples were positive for E. coli. On the other hand, 18 out of 200 (9 %) swab samples from pregnant women with history of RUTIs, while 10 out of 245 (4.08 %) swab samples from healthy pregnant women were positive for E. coli. Pregnant women older than 40 years had the highest prevalence of E. coli (12.71 %). Statistical significant differences were seen between the types of samples and prevalence of E. coli (p < 0.01) and between the age of women and prevalence of E. coli (p < 0.05). Table 2 indicates the antimicrobial resistance pattern of E. coli strains isolated from pregnant women with RUTIs and healthy pregnant women. E. coli strains from our investigation harbored the highest levels of resistance against ampicillin (96.42 %), tetracycline (85.71 %), amikacin (71.42 %), ciprofloxacin (67.85 %) and gentamycin (58.71 %) antibiotic agents. Levels of antibiotic resistances in pregnant women with history of RUTIs were higher than those of healthy pregnant women (p < 0.05). The most effective antibiotic agents against E. coli strains from the high vaginal swab samples of pregnant women were imipenem (3.57 %), mezlocillin (25 %) and nitrofurantoin (25 %).
RESULTS

DISCUSSION
The results of present study are the first prevalence report of the UPEC strains and their antibiotic resistance pattern in the swab samples taken directly from the high vaginal swab samples of pregnant women. Probably the pregnant women of our study had vaginitis due to the presence of UPEC strains. History of RUTIs can accentuate the above hypothesis. It is commonly accepted that a high frequency of UTI during pregnancy would be due to physiological changes the human body undergoes during pregnancy. Bacterial vaginosis has been reported as the most common vaginal infection. Its prevalence varies from 10 to 65 % [10] . Many serious obstetric and gynecological complications have been associated with bacterial vaginosis. Such obstetric complications included premature rupture of membranes, preterm labor and delivery, endometritis and chorioamnionitis [18] . We found that the prevalence of UPEC strains in the swab samples of pregnant women with history of RUTIs and in healthy pregnant women were 9 and 4.08 %, respectively. Transmission of pathogenic strains of E. coli from the urinary tract to the vagina could be the main factor for the higher prevalence of UPEC strains in the high vaginal swab samples of pregnant women with history of RUTIs. The observed prevalence of UPEC strains in the high vaginal swab samples of healthy pregnant women could also be due to the fact that they may have been infected with UTIs in the past or even vaginitis which may been forgotten or become asymptomatic. The results of our investigation revealed that pregnancy in older ages could be the main risk factors in the transmission of infections from urinary into the reproductive system.
Our study also focused on the antibiotic resistance pattern of UPEC strains isolated from pregnant women. As a result of high and irregular prescription of antibiotic coupled with high levels of UPEC resistance against commonly used antibiotics, it was not surprising that most of the UPEC strains of our study were resistant against ampicillin, tetracycline, amikacin, ciprofloxacin, gentamycin, cotrimoxazole, norfloxacin, ofloxacin, nitrofurantoin, cephalothin and clindamycin. This observation has been corroborated by some literature reports. Barati et al [19] revealed that urine samples of pregnant women were contaminated with E. coli strains. They showed that the sensitivity of E. coli isolates against antibiotics were coamoxiclav (5.72 %), ampicillin (8. [20] . Guiral et al [21] in a study which was conducted on prevalence of E. coli in the genital tracts of the pregnant women, reported 86 out of 648 samples (13 %) which was higher than our results. High prevalence of UPEC strains in the vaginal samples of pregnant women have also been reported previously [22] [23] [24] . Prevalence of antibiotic resistance in the E. coli strains isolated from pregnant women of Tanzania against ampicillin, sulfamethazoletrimethoprim, tetracycline, nitrofurantoin, ceftriaxone, gentamycin, ciprofloxacin and imipenem were 52.9, 64.7, 58.8, 5.9, 29.4, 5.9, 11.8 and 0 %, respectively [25] . Similar results have been reported from Nigeria [25] , Iraq [27] and Argentina [28] .
CONCLUSION
As far as we know, the present study is the first prevalence report on antibiotic resistance pattern of UPEC strains in pregnant women with history of RUTIs. The findings indicate that RUTIs and pregnancy in old age may be the two most important risk factors for the transmission of UPEC strains from the urinary tract to the vagina. Due to the clinical importance of the presence of resistant UPEC strains in upper part of the vaginal of pregnant women, accurate identification of these women and their primary treatment with imipenem, mezlocillin and nitrofurantoin may be effective in the management and prevention of reproductive complications. Further studies are required to evaluate the exact role of UPEC strains in pregnant women.
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